Home|Journals Follow on Twitter| Subscribe to List

Directory for Medical Articles
 

Open Access

3



Predisposing role of heterozygote MTHFR A1298C mutation in venous thrombosis in a pregnant patient: A case report

Ayse Arduc, Serhat Isik,, Berçem Aycicek Dogan, Ufuk Ozuguz, Gulhan Akbaba, Dilek Berker, Serdar Guler.

Abstract
Congenital and acquired thrombophilia are associated with an increased risk of pregnancy-associated venous thrombosis (VT). Several genetic mechanisms have been investigated for their possible relationship with VT. Methyl tetrahydrofolate reductase gene polymorphisms are frequently in the MTHFR gene, which leads to a C to T change at position 677, has been suggested to alter the thrombohemostasis process and thrombophilia (1). Also, it has been found that MTHFR C1298C or MTHFR A1298C have no effect on the risk of VT (1). Herein, we describe deep VT (DVT) secondary to heterozygous MTHFR A1298C mutation in pregnant woman.

Key words: Pregnancy; MTHFR A1298C mutation; Venous thrombosis



Share this Article


Advertisement
American Journal of Physiology, Biochemistry and Pharmacology

SUBMIT YOUR ARTICLE NOW


ScopeMed.com
ScopeMed Home
Follow ScopeMed on Twitter
BiblioCAM
Author Tools
eJPort Journal Hosting
About ScopeMed
License Information
Terms & Conditions
Privacy Policy
Suggest a Journal
Publisher Login
Contact Us

The articles in Scopemed are open access articles licensed under the terms of the Creative Commons Attribution-NonCommercial-ShareAlike 4.0 International License (https://creativecommons.org/licenses/by-nc-sa/4.0/) which permits unrestricted, non-commercial use, distribution and reproduction in any medium, provided the work is properly cited.
ScopeMed is a Database Service for Scientific Publications. Copyright © ScopeMed® Information Services.
Scopemed Buttons